🇺🇸 Fluticasone propionate nasal spray. in United States

766 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Epistaxis — 183 reports (23.89%)
  2. Drug Ineffective — 127 reports (16.58%)
  3. Headache — 90 reports (11.75%)
  4. Nasal Discomfort — 76 reports (9.92%)
  5. Dyspnoea — 58 reports (7.57%)
  6. Product Use Issue — 49 reports (6.4%)
  7. Cough — 48 reports (6.27%)
  8. Product Quality Issue — 48 reports (6.27%)
  9. Recalled Product Administered — 48 reports (6.27%)
  10. Nasal Congestion — 39 reports (5.09%)

Source database →

Fluticasone propionate nasal spray. in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fluticasone propionate nasal spray. approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fluticasone propionate nasal spray. in United States?

Benha University is the originator. The local marketing authorisation holder may differ — check the official source linked above.